Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Osteoporosis × Toremifene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms, Hormone-Dependent 3 Carcinoma, Lobular 3 Carcinoma, Ductal, Breast 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Prostatic Intraepithelial Neoplasia 2 Fractures, Bone 2 Precancerous Conditions 1 Osteoporosis 1 Neoplasms 1 Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 2 Denosumab 2 Toremifene 1 Testosterone 1 Risedronic Acid 1 Letrozole 1 Kyphoplasty 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00129142 2013-11-15

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

GTx

Phase 3 Completed

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡